United States · FDA National Drug Code directory
Hydralazine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-293_26a904df-7070-489e-b0e0-67167a817944
- Product NDC
- 67877-293
- Form
- TABLET
- Composition / generic term
- Hydralazine Hydrochloride
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100524
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDRALAZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (67877-293-01) · 67877-293-01
- 500 TABLET in 1 BOTTLE (67877-293-05) · 67877-293-05
- 1000 TABLET in 1 BOTTLE (67877-293-10) · 67877-293-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →